Neuron23

Last updated: October 22, 2025
Founder Adam Knight
Founder Adam Knight
Country: USA | Funding: $310M (+)

Website: https://neuron23.com/

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.

Competitors